促甲状腺激素与老年心血管疾病的相关性研究进展

doi:10.3969/j.issn.1003-9198.2023.07.022

摘要/Abstract

中图分类号:

R 54
R 581.2

乔茹月, 秦纲. 促甲状腺激素与老年心血管疾病的相关性研究进展[J]. 实用老年医学, 2023, 37(7): 741-745.

[1] BOUCAI L, SURKS M I. Reference limits of serum TSH and free T4 are significantly influenced by race and age in an urban outpatient medical practice[J]. Clin Endocrinol:Oxf, 2009, 70(5): 788-793.
[2] SURKS M I, BOUCAI L. Age- and race-based serum thyrotropin reference limits[J]. J Clin Endocrinol Metab, 2010, 95(2): 496-502.
[3] BOUCAI L, HOLLOWELL J G, SURKS M I. An approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits[J]. Thyroid, 2011, 21(1): 5-11.
[4] VADIVELOO T, DONNAN P T, MURPHY M J, et al. Age- and gender-specific TSH reference intervals in people with no obvious thyroid disease in Tayside, Scotland: the Thyroid Epidemiology, Audit, and Research Study(TEARS)[J]. J Clin Endocrinol Metab, 2013, 98(3): 1147-1153.
[5] CLERICO A, TRENTI T, ALOE R, et al. A multicenter study for the evaluation of the reference interval for TSH in Italy(ELAS TSH Italian Study)[J]. Clin Chem Lab Med, 2018, 57(2): 259-267.
[6] CAI J, FANG Y, JING D, et al. Reference intervals of thyroid hormones in a previously iodine-deficient but presently more than adequate area of Western China: a population-based survey[J]. Endocr J, 2016, 63(4): 381-388.
[7] XING D, LIU D, LI R, et al. Factors influencing the reference interval of thyroid-stimulating hormone in healthy adults: a systematic review and meta-analysis[J]. Clin Endocrinol:Oxf, 2021, 95(3): 378-389.
[8] JONKLAAS J, RAZVI S. Reference intervals in the diagnosis of thyroid dysfunction: treating patients not numbers[J]. Lancet Diabetes Endocrinol, 2019, 7(6): 473-483.
[9] KRATZSCH J, FIEDLER G M, LEICHTLE A, et al. New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid[J]. Clin Chem, 2005, 51(8): 1480-1486.
[10] MUSA I R, ALI N I, ELSEED S A, et al. Reference intervals of thyroid hormones in Khartoum, Sudan[J]. BMC Res Notes, 2018, 11(1): 729.
[11] 中华医学会内分泌学分会.成人甲状腺功能减退症诊治指南[J]. 中华内分泌代谢杂志, 2017, 33(2): 167-180.
[12] ZHAI X, ZHANG L, CHEN L, et al. An age-specific serum thyrotropin reference range for the diagnosis of thyroid diseases in older adults: a cross-sectional survey in China[J]. Thyroid, 2018, 28(12): 1571-1579.
[13] GROSSMAN A, WEISS A, KOREN-MORAG N, et al. Subclinical thyroid disease and mortality in the elderly: a retrospective cohort study[J]. Am J Med, 2016, 129(4): 423-430.
[14] OCHS N, AUER R, BAUER D C, et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality[J]. Ann Intern Med, 2008, 148(11): 832-845.
[15] HYLAND K A, ARNOLD A M, LEE J S, et al. Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study[J]. J Clin Endocrinol Metab, 2013, 98(2): 533-540.
[16] 崔俊芳,祁琨,陈芸. 老年冠心病患者合并亚临床甲状腺功能减退的临床指标分析[J]. 世界最新医学信息文摘, 2017, 17(83): 128.
[17] 宋梅, 黎兰芳, 戴喜艳, 等. 老年冠心病患者甲状腺激素水平分析 [J]. 当代医学, 2016, 22(16): 52-53.
[18] WARING A C, HARRISON S, SAMUELS M H, et al. Thyroid function and mortality in older men: a prospective study[J]. J Clin Endocrinol Metab, 2012, 97(3): 862-870.
[19] ZHANG M, SARA J D S, MATSUZAWA Y, et al. Clinical outcomes of patients with hypothyroidism undergoing percutaneous coronary intervention[J]. Eur Heart J, 2016, 37(26): 2055-2065.
[20] LEE Y, LIM Y H, SHIN J H, et al. Impact of subclinical hypothyroidism on clinical outcomes following percutaneous coronary intervention[J]. Int J Cardiol, 2018, 253: 155-160.
[21] 孙宇, 王艳, 徐书杭, 等. 老年亚临床甲状腺功能减退症与急性冠脉综合征的相关性分析 [J]. 实用老年医学, 2022, 36(2): 164-167.
[22] LI R C, ZHANG L, LUO H, et al. Subclinical hypothyroidism and anxiety may contribute to metabolic syndrome in Sichuan of China: a hospital-based population study[J]. Sci Rep, 2020, 10(1): 2261.
[23] 李银, 崔浩然, 罗义. 亚临床甲状腺功能减退对代谢综合征及颈动脉粥样硬化的影响 [J]. 岭南心血管病杂志, 2016, 22(2): 188-191,226.
[24] TIAN L, SONG Y, XING M, et al. A novel role for thyroid-stimulating hormone: up-regulation of hepatic 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase expression through the cyclic adenosine monophosphate/protein kinase A/cyclic adenosine monophosphate-responsive element binding protein pathway[J]. Hepatology, 2010, 52(4): 1401-1409.
[25] MA S, JING F, XU C, et al. Thyrotropin and obesity: increased adipose triglyceride content through glycerol-3-phosphate acyltransferase 3[J]. Sci Rep, 2015, 5: 7633.
[26] TIAN L, ZHANG L, LIU J, et al. Effects of TSH on the function of human umbilical vein endothelial cells[J]. J Mol Endocrinol, 2014, 52(2): 215-222.
[27] LIU X L, HE S, ZHANG S F, et al. Alteration of lipid profile in subclinical hypothyroidism: a meta-analysis[J]. Med Sci Monit, 2014, 20: 1432-1441.
[28] 刘星君, 滕卫平, 施秉银, 等. 亚临床甲状腺功能异常对血脂的影响 [J]. 中华内科杂志, 2010, 49(2): 151-152.
[29] GONG Y, MA Y, YE Z, et al. Thyroid stimulating hormone exhibits the impact on LDLR/LDL-c via up-regulating hepatic PCSK9 expression[J]. Metabolism, 2017, 76: 32-41.
[30] TÜREMEN E E, ÇETINARSLAN B, ÇAHIN T, et al. Endothelial dysfunction and low grade chronic inflammation in subclinical hypothyroidism due to autoimmune thyroiditis[J]. Endocr J, 2011, 58(5): 349-354.
[31] YANG C, LU M, CHEN W, et al. Thyrotropin aggravates atherosclerosis by promoting macrophage inflammation in plaques[J]. J Exp Med, 2019, 216(5): 1182-1198.
[32] GAO F. Variation tendency of coagulation parameters in different hypothyroidism stages [J]. Acta Endocrinol:Buchar, 2016, 12(4): 450-454.
[33] GAO F, WANG G, XU J. Alteration of hemostatic parameters in patients with different levels of subclinical hypothyroidism and the effect of L-thyroxine treatment[J]. Ann Clin Lab Sci, 2017, 47(1): 29-35.
[34] 殷小红, 马卫国, 谢传庆, 等. 凝血相关指标与亚临床甲状腺功能减退症患者病情的关系 [J]. 血栓与止血学, 2020, 26(5): 804-805.
[35] 高芳, 张云娜, 赵乃蕊, 等. 不同程度亚临床甲状腺功能减退症患者止凝血相关指标变化的研究 [J]. 检验医学, 2018, 33(2): 110-114.
[36] 王旭东, 李哲, 贾永平. 亚临床甲状腺功能减退症与冠心病的相关关系研究 [J]. 中西医结合心脑血管病杂志, 2016, 14(1): 55-57.
[37] STOTT D J, RODONDI N, KEARNEY P M, et al. Thyroid hormone therapy for older adults with subclinical hypothyroidism[J]. N Engl J Med, 2017, 376(26): 2534-2544.
[38] GENCER B, MOUTZOURI E, BLUM M R, et al. The impact of levothyroxine on cardiac function in older adults with mild subclinical hypothyroidism: a randomized clinical trial[J]. Am J Med, 2020, 133(7): 848-856.e5.
[39] RODONDI N, DEN ELZEN W P J, BAUER D C, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality[J]. JAMA, 2010, 304(12): 1365-1374.
[40] 姜飞飞. 老年冠心病合并亚临床甲减42例临床分析 [J]. 中国实用医药, 2018, 13(24): 99-100.
[41] SOMWARU L L, ARNOLD A M, JOSHI N, et al. High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over[J]. J Clin Endocrinol Metab, 2009, 94(4): 1342-1345.
[42] FLYNN R W, BONELLIE S R, JUNG R T, et al. Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy[J]. J Clin Endocrinol Metab, 2010, 95(1): 186-193.
[43] ROZING M P, HOUWING-DUISTERMAAT J J, SLAGBOOM P E, et al. Familial longevity is associated with decreased thyroid function[J]. J Clin Endocrinol Metab, 2010, 95(11): 4979-4984.
[44] ATZMON G, BARZILAI N, HOLLOWELL J G, et al. Extreme longevity is associated with increased serum thyrotropin[J]. J Clin Endocrinol Metab, 2009, 94(4): 1251-1254.
[45] LAURBERG P, ANDERSEN S, CARLEA, et al. The TSH upper reference limit: where are we at?[J]. Nat Rev Endocrinol, 2011, 7(4): 232-239.

促甲状腺激素与老年心血管疾病的相关性研究进展

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

推荐阅读 10

[1]	李晓燕, 郁志明. 老年心房颤动合并焦虑状态的研究进展[J]. 实用老年医学, 2024, 38(10): 979-982.
[2]	顾崇怀, 项学军, 郑元喜, 乔锐, 林松. 达格列净对接受冠状动脉介入治疗的伴有射血分数降低的心力衰竭合并2型糖尿病老年病人疗效观察[J]. 实用老年医学, 2024, 38(10): 1025-1029.
[3]	刘瑾, 黄艳秋, 朱毅, 卓莉莉. 沙库巴曲缬沙坦钠对老年慢性心力衰竭病人的影响[J]. 实用老年医学, 2024, 38(10): 1030-1033.
[4]	徐寿勇, 袁勇. 老年病人开展双低剂量CT冠状动脉造影的可行性研究[J]. 实用老年医学, 2024, 38(10): 1054-1058.
[5]	刘琳, 邬青, 张静, 毛芳莹, 余璐, 任艺婷, 方婷. 老年心力衰竭病人症状感知现状及影响因素分析[J]. 实用老年医学, 2024, 38(5): 461-437.
[6]	王超, 陈晓君. 热带气候对东北地区老年原发性高血压病人血压、外周血microRNA-146a及Hcy的影响[J]. 实用老年医学, 2024, 38(5): 470-437.
[7]	刘倩慧, 姚子俊, 何玉立, 徐云凡, 吴军. 老年2型糖尿病合并慢性心力衰竭病人HbA1c水平对心脏结构和功能的影响[J]. 实用老年医学, 2024, 38(5): 491-437.
[8]	张丽莉, 李静, 丁林锋, 孙静娴, 蔡静波. 颈动脉粥样硬化斑块对非瓣膜性心房颤动病人缺血性脑卒中事件的预测价值[J]. 实用老年医学, 2024, 38(3): 236-239.
[9]	查志敏, 刘欢, 王向明, 李秋爽, 郭妍. 心脏瓣膜钙化对老年冠心病病人预后的影响[J]. 实用老年医学, 2024, 38(3): 245-250.
[10]	陈映泉, 钟勇. 心血管老化的机制、标志物和治疗[J]. 实用老年医学, 2024, 38(3): 299-303.
[11]	朱晨晨, 秦海东. 斑块侵蚀在急慢性冠脉综合征发生发展中的作用[J]. 实用老年医学, 2024, 38(3): 308-311.
[12]	程清, 徐艳, 陈国飞, 邓心悦. 血清血管紧张素Ⅱ和一氧化氮水平与老年慢性心力衰竭病人认知功能障碍的相关性[J]. 实用老年医学, 2024, 38(2): 132-135.
[13]	章颖, 谢玲, 叶佳琦, 羌文慧, 严晓云, 姜英, 张清. 层粘连蛋白与老年急性心肌梗死病人主要不良心血管事件的相关性[J]. 实用老年医学, 2024, 38(2): 149-151.
[14]	段力丹, 习玲, 许建萍. 射血分数正常的老年高血压病人TyG指数与左心室舒张功能的相关性分析[J]. 实用老年医学, 2024, 38(2): 152-156.
[15]	范婷泳, 袁丽, 杨小玲, 陈茜. Caprini量表评估老年糖尿病病人静脉血栓栓塞症的效果[J]. 实用老年医学, 2023, 37(12): 1233-1237.